On April 26, the Food and Drug Administration (FDA) authorized several NJOY Ace vaping products.
It is the most significant positive decision to date on the premarket tobacco product applications (PMTAs) that all vapor companies had to file with the agency.
Decisions were expected in September 2021; as late as this move comes, it’s an official endorsement of sorts of vaping as a harm reduction alternative to cigarettes, and offers some hope to former smokers who rely on far-less-harmful vapes.
NJOY can now continue to legally sell its NJOY Ace device without fear of it being removed from the market, along with three tobacco-flavored pods: Classic Tobacco in 2.4 percent and 5 percent nicotine strength, and Rich Tobacco in 5 percent.
According to Nielsen and analyst reports, which measure financial data typically from convenience stores (and not vape shops), NJOY is the third-largest vape manufacturer in the United States after Vuse and Juul, holding a little more than 3 percent of the market. Juul tends to hover around 38 percent and Vuse—owned by R.J. Reynolds, a subsidiary of British American Tobacco—near 30 percent.
Alex Norcia – Filter – 2022-04-26.
Want More Investigative Content?
